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Objective: To improve the knowledge on the metabolite composition of Endopleura
uchi bark, concerning phenolic compounds, and to evaluate some of its biological ca-
pacities for further possible exploitation in food and pharmaceutical industries associated
to their health-promoting qualities.
Methods: Two different extracts (infusion and hydroethanolic) were studied concerning
phenolic composition and biological potential.
Results: Five compounds were determined by HPLC-DAD, being bergenin the major
one. In general way, infusion presents a greater richness in these metabolites. The anti-
oxidant, acetylcholinesterase, butyrylcholinesterase, a-glucosidase and antibacterial ac-
tivity were checked by in vitro assays. A dose-dependent response was noticed against
DPPH, superoxide and nitric oxide radicals, acetylcholinesterase, butyrylcholinesterase
and against a-glucosidase inhibitory assay. Antibacterial capacity of both extracts was
investigated against Gram-positive and Gram-negative bacteria, being more effective
against the ﬁrst one. The concentrations of infusion extract tested here revealed that is
non-toxic for intestinal (Caco-2) cells line.
Conclusions: The results suggest that the extracts of Endopleura uchi may be interesting
for incorporating in pharmaceutical preparations for human health, since it can suppress
hyperglycaemia and inhibit cholinesteases, and or as food additive due to its antiradical
and antibacterial activities.1. Introduction
Plants have been used for medicinal purposes for many
centuries. Today, herbal medicines are being employed world-
wide in a variety of health care settings and as home remedies. In
some developing countries, communities rely heavily on tradi-
tional health practitioners and medicinal plants to meet theirprimary health care needs. In many industrialized countries
herbal medicines are gaining popularity as alternative and
complementary therapies. The World Health Organization esti-
mates that 65%–80% of the people in developing countries use
traditional medicine for primary health care and 85% of that
involves the use of plant extracts [1].
Among medicinal plants, some endemic species can be used
for the production of raw materials or preparations containing
phytochemicals with signiﬁcant biological activities and conse-
quent health beneﬁts. Plants from tropical countries constitute a
genuine biological source of natural metabolites, which are
biosynthesized in response to abiotic and biotic stress for sur-
viving in such extreme conditions, like excessive variations in
temperature, desiccation, ultraviolet degradation, water stress
and exposure to herbivores [2].open access article under the CC BY-NC-ND
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a native tree of the Brazilian Amazon rainforest and is widely
spread in the Amazon basin [1]. Popularly known as ‘uxi-
amarelo’, ‘cumateˆ’, ‘axua´’, ‘pururu’, ‘uxi-liso’, ‘uxi-ordina´rio’
or ‘uchi-pucu’. The erect trees have pale gray bark and reach
between 23 and 30 m in height, with a stem diameter over
one meter [3,4].
There are few studies of E. uchi and are concentrated in the
fruits that are appreciated in the region [5,6]. The pulp of the fruit
has a high content of fat, predominantly oleic acid [7] and
carotenoids, mostly trans-b-carotene [5]. However, the bark is
widely commercialized at fairs, markets and even drugstores,
being prescribed in the form of tea, for arthritis, cholesterol,
diabetes, diarrhea treatments, as an anti-inﬂammatory, also
against tumors and uterine infections [1,6,8,9].
The phytochemical screening of the bark revealed the pre-
dominance of tannins, coumarins and saponins as the main
classes of secondary metabolites [10]. In a previous study, Luna
[11] isolated two pentacyclic triterpenoids of the oleanane series
(maslinic acid and methyl maslinate) and two coumarins
(bergenin and dimethyl bergenin) from crude ethanolic
extracts of the bark. Nunomura and co-authors [9] also isolated
bergenin from E. uchi bark. Previously, bergenin has been
isolated from E. uchi fruits [5], and another medicinal plants
like Bergenial crassifolia, Mallotus philippinensis, Corylopsis
spicata, Caesalpinia digyna, Mallotus japonicas, Humiria
balsamifera and Sacoglottis gabonensis [9,12].
Bergenin alias Cuscutin is trihydroxybenzoic acid glycoside.
It is a C-glucoside of 4-O-methyl gallic acid is a colouress
crystalline polyphenol, it is hydrolysable tannin and an iso-
coumarin derivative with three hydroxyl (OH) groups and two
phenolic OH groups [12]. Bergenin has been reported to have
several biological activities, such as anti-inﬂammatory, antioxi-
dant, hepatoprotective, neuroprotective, antidiabetic/antiobesity,
antiulcer, antiarrhythmic, anti-HIV, antibacterial, antifungal,
immunomodulatory and burn wound healing effects [1,5,6,12–14].
Thus, the aim of the present work was to improve the
knowledge on the metabolite composition of E. uchi bark,
concerning phenolic compounds, and to evaluate some of its
biological capacities for further possible exploitation in food and
pharmaceutical industries associated to their health-promoting
qualities. For these purposes two different extracts (infusion
and hydroethanolic) from E. uchi bark were tested for their
antioxidant, cholinesteases, a-gucosidase and antibacterial ca-
pacities. The extract with greater biological potential was used to
evaluate the cytotoxic against Caco-2 cell line. As far as we
know, it is the ﬁrst time this species is evaluated concerning
these properties.
2. Materials and methods
2.1. Standards and reagents
All chemicals used were of analytical grade. The standard
compounds were purchased from various suppliers: bergenin
was from Selleckchem (Boston, USA).1,1-diphenyl-2-
picrylhydrazyl (DPPH), sodium pyruvate, thiazolyl blue tetra-
zolium bromide (MTT), b-nicotinamide adenine dinucleotide
reduced form (NADH), phenazine methosulfate, nitro-
tetrazolium blue chloride, 5,50-dithio-bis(2-nitrobenzoic acid),
sulphanilamide, acetylcholinesterase (AChE) from electric eel
(type Ⅵ-s, lyophilized powder), acetylthiocholine iodide,butyrylcholinesterase (BuChE) from equine serum (lyophilized
powder), S-butyrylthiocholine chloride, a-glucosidase (type I
from baker's yeast), 4-nitrophenyl a-D-glucopyranoside (PNP-
G), sodium nitroprusside dehydrate, dimethyl sulfoxide
(DMSO), dichloromethane, methanol (MeOH), acetonitrile and
gentamicin were purchased from Sigma–Aldrich (St. Louis,
MO, USA). N-(1-Naphthyl)ethylenediamine dihydrochloride,
ethanol and potassium dihydrogen phosphate were obtained
from Merck (Darmstadt, Germany). Hydrochloric and ortho-
phosphoric acid were purchased from Panreac (Barcelona,
Spain). Mueller Hinton Broth (MHB) and Mueller Hinton Agar
(MHA) media were purchased from Lioﬁlchem (Teramo, Italy).
Dulbecco's modiﬁed Eagle medium (DMEM), phosphate-
buffered saline, hepes buffered saline, nonessential amino
acids, fetal bovine serum, antibiotic (10000 U/mL penicillin,
10000 mg/mL streptomycin), fungizone (250 mg/mL amphoter-
icin B), human transferrin (4 mg/mL) and trypsin-EDTA were
from Invitrogen (Gibco Laboratories; Lenexa, KS). Water was
deionised using a Milli-Q water puriﬁcation system (Millipore,
Bedford, MA, USA).
2.2. Plant samples
Dried barks of E. uchi, corresponding to a mixture of
different individuals, were from a medicinal plants distributor
(Morais e Costa & Cª. Lda, Portugal). Voucher specimen was
deposited at Laborato´rio de Farmacognosia, Faculdade de
Farma´cia, Universidade do Porto (ER-MC-022013).
2.3. Extracts' preparation
E. uchi barks were powdered and sieved in order to obtain a
mean particle size lower than 910 mm and used for the prepa-
ration of two different extracts. The conditions used for
extraction were adapted from those proposed by Teixeira and
Silva [15].
Infusion: 1 g of dried material was boiled with 100 mL of
water for three minutes, as indicated in the instructions provided
in the packing. Thus, it mimics the way how it is usually pre-
pared for human consumption. The resulting extract was ﬁltered
through a Bu¨chner funnel, frozen and lyophilized. The extract
was kept in a desiccator, in the dark, until analysis. The yield of
E. uchi infusion extract was (8.10 ± 0.09) g from starting dry
material.
Ethanolic/water: 1 g of dried material were extracted with
ethanol: water (1:1) mixture, as follows: 30 min of sonication,
1 h of stirring (200 rpm) maceration at room temperature, plus
30 min of sonication. The obtained extract was ﬁltered through a
0.45 mm polytetraﬂuoroethylene membrane (Millipore, Bedford,
MA), evaporated under reduced pressure and kept at −20 C
until further analysis. The yield of E. uchi hydroethanolic extract
was (7.00 ± 0.74) g from starting dry material.
Extractions were carried out in triplicate.
2.4. Phenolic compounds
Infusion and hydroethanolic extracts were redissolved in
methanol (30 mg) and analysed in a HPLC/DAD (Gilson) as
described before [16] for phenolic compounds determination.
The obtained extracts were ﬁltered through a 0.45 mm
polytetraﬂuoroethylene membrane.
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HPLC unit (Gilson), using a previously described procedure [16].
Twenty microlitres of each aqueous extract were analysed on an
analytical HPLC unit (Gilson), using a Spherisorb ODS2
(25.0 cm × 0.46 cm; 5 mm, particle size; Waters, Milford,
MA) column. The solvent system used was a gradient of
water: formic acid (19:1) (A) and methanol (B), starting with
5% methanol and installing a gradient to obtain 15% B at
3 min, 25% B at 13 min, 30% B at 25 min, 35% B at 35 min,
45% B at 39 min, 45% B at 42 min, 50% B at 44 min, 55%
B at 47 min, 70% B at 50 min, 75% B at 56 min and 80% B
at 60 min, at a solvent ﬂow rate of 0.9 mL/min. Detection was
achieved with a Gilson diode array detector. Spectral data
from peaks were accumulated in the range 200–400 nm, and
chromatograms were recorded at 280, 320 and 350 nm. The
data were processed on Unipoint System software (Gilson
Medical Electronics, Villiers-le-Bel, France). Phenolic com-
pounds quantiﬁcation was achieved by measuring the absor-
bance recorded in the chromatograms relative to external
standards. Because standards of bergenin derivatives were not
available, all compounds were quantiﬁed as bergenin. Bergenin
and bergenin derivatives were determined at 280 nm. This
procedure was performed in triplicate.
2.5. Antioxidant activity
The infusion and hydroalcoholic extracts were used for
screening of the antioxidant activity. Spectrophotometric
microassays were performed in a Multiskan Ascent plate reader
(Thermo, Electron Corporation).
DPPH assay: the disappearance of DPPH was monitored
spectrophotometrically at 515 nm, following a described pro-
cedure [17]. For each extract, a dilution series (ﬁve different
concentrations) was prepared in a 96-well plate. Three experi-
ments were performed in triplicate.
Nitric oxide assay: the scavenging activity was determined as
before [17]. The chromophore formed with Griess reagent was
read at 562 nm. For each extract, ﬁve different concentrations
were tested. Three experiments were performed in triplicate.
Superoxide radical assay: the effect of the lyophilized ex-
tracts on superoxide radical-induced reduction of nitro-
tetrazolium blue chloride was monitored at 562 nm. Superoxide
radicals were generated by the NADH/phenazine methosulfate
system, as previously reported [17]. All components were
dissolved in phosphate buffer (19 mM, pH 7.4). For each
extract, ﬁve different concentrations were tested. Three
experiments were performed in triplicate.
2.6. AChE and BuChE inhibitory activity
The inhibition of both AChE and BuChE activity was
determined based on Ellman's method, as previously reported
[17]. The absorbance was measured at 405 nm and the rates of
reactions were calculated by Ascent Software version 2.6
(Thermo; electron corporation). Three experiments were
performed in triplicate.
2.7. a-Glucosidase inhibitory activity
a-Glucosidase inhibitory activity was assessed according to
the methods described by Silva et al. [17]. Brieﬂy, each wellcontained 100 mL of 2 mM PNP-G in 100 mM potassium
phosphate buffer (pH 7.0) and 20 mL of the extract in buffer. The
reaction was initiated by the addition of 100 mL of the enzyme
solution (56.6 mU/mL). The plates were incubated at 37 C for
10 min. The absorbance of 4-nitrophenol released from PNP-G
at 400 nm was measured. The increase in absorbance was
compared with that of the control (buffer instead of sample so-
lution) to calculate the inhibitory activity.
2.8. Antibacterial activity
The study included nine bacteria species Staphylococcus
aureus (S. aureus) (ATCC 20231), Staphylococcus epidermidis
(ATCC 20044), Salmonella typhimurium (ATCC 43971),
Proteus mirabilis (ATCC4479), Escherichia coli (E. coli)
(ATCC 30083), Pseudomonas aeruginosa (P. aeruginosa)
(ATCC 50071), Bacillus cereus (B. cereus) (ATCC 31),
Enterococcus faecalis (ATCC20477) and Micrococcus luteus
(M. luteus) (ATCC 20030), these species were selected due
their great importance in foods and clinical [18,19]. Cultures
were obtained from the Department of Microbiology, Faculty
of Pharmacy, Porto University (Portugal). S. aureus (ATCC
25923) was used for quality control in antibacterial assays.
All microorganisms were stored in broth medium with 20%
glycerol at −70 C and sub-cultured in MHA before each
test, to ensure optimal growth conditions and purity. Minimum
inhibitory concentration (MIC) was determined by employing
broth microdilution methods based on the Clinical and Labo-
ratory Standards Institute guidelines, reference documents
M07-A8 and M100-S19, with minor modiﬁcations [18,20].
Brieﬂy, the suspensions of bacteria cultures were prepared in
ampoules containing 2 mL of NaCl 0.85% suspension
medium (api®, Biome´rieux, Marcy l'E'toile, France). After
adjusting the turbidity to 0.5 McFarland, suspensions were
diluted in MHB till the ﬁnal bacterial density of
1.5 × 106 CFU/mL. The MIC of extracts was determined by
two-fold serial dilution method, in 96-well plates. The initial
concentration was 8.0 mg/mL of dry matter, for each tested
species. Brieﬂy, 50 mL of the bacterial suspension was added in
each well, which contained 50 mL of extract dilutions in MHB
medium. The maximum DMSO concentration did not exceed
1.25% (v/v). The plates were incubated at 37 C in a humidiﬁed
atmosphere containing 5% CO2, without agitation for 18–24 h
for both Gram positive and Gram negative bacteria. The MIC
was determined as the lowest concentration of dried extracts
inhibiting the visual growth of the test culture on the micro-
plate. Gentamicin MIC for S. aureus (ATCC 25923) was
determined as quality control, and the result was within the
recommended limits [20]. Sterility and positive controls in MHB
medium alone and with 1.25% of DMSO (v/v) were included.
Positive control wells contained microorganisms without
antibiotics. The experiments were performed in duplicate and
repeated independently three times, yielding essentially the
same results.
The determination of the minimum lethal concentration
(MLC) of extracts was also accessed. The MLC was determined
after 18–24 h of incubation for both Gram positive and Gram
negative bacteria, by removing 20 mL of the contents from all
wells showing no visible growth to MHA plates. The plates were
incubated at 37 C. The MLC was deﬁned as the lowest con-
centration showing 100% growth inhibition.
Figure 1. HPLC/DAD phenolic proﬁle from infusion of E. uchi (detection
at 280 nm). Peaks: (1) bergenin derivative 1; (2) bergenin derivative 2; (3)
bergenin derivative 3; (4) bergenin derivative 4; (5) bergenin.
Table 1
Phenolic compounds proﬁle of E. uchi extracts (mg/kg).
Compounds RT Ethanol: water Infusion
1 Bergenin
derivative 1
7.3 8903.9 ± 263.9a 9 19.3 ± 14.4
2 Bergenin
derivative 2
7.8 3684.8 ± 45.5a 8527.7 ± 65.6
3 Bergenin
derivative 3
8.9 8748.1 ± 67.1a 15143.9 ± 249.3
4 Bergenin
derivative 4
10.7 922.9 ± 32.6a 813.4 ± 22.5a
5 Bergenin 12.6 157029.2 ± 253.1a 200239.8 ± 383.3P
179289.0 225644.2
Values are expressed as mean ± standard deviation of three assays;
P
:
sum of the determined phenolic compounds; nq: not quantiﬁed. RT:
retention time (min).
a Compared the samples there are not signiﬁcant differences (P > 0.05).
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Human colorectal adenocarcinoma cell line (Caco-2) from
the American Type Culture Collection (LGC Standards S.L.U.,
Spain) was routinely cultured using DMEM supplemented with
10% fetal bovine serum, 1% nonessential amino acids, 1%
antibiotic, 1% fungizone and 6 mg/mL transferrin. Cells were
cultured at 37 C in a 5% CO2 incubator as previously described
[21]. Cells were washed with hepes buffered saline, trypsinized
and sub-cultured in 48-well plates at a density of 25000 cells/
cm2. All the assays were performed after conﬂuence. The infu-
sion extract (16–1000 mg/mL) was dissolved in medium con-
taining 0.5% (v/v) DMSO. The ﬁnal concentration of DMSO did
not affect cellular viability. To determine the effect of the
compounds/extracts on cells, viability was assessed 24 h after
exposure.
MTT assay was performed by MTT reduction to formazan by
viable cells was evaluated according to a described procedure
[22]. After rejecting the cell culture supernatant, the cells were
incubated with 1 mL of MTT solution (0.5 mg/mL in
supplemented DMEM) for 30 min, at 37 C. After this period,
the supernatant was eliminated and 1 mL of DMSO was
added to each well in order to solubilise the purple crystals of
formazan that was formed. The absorbance of the different
solutions was then measured using a Multiskan Ascent plate
reader (Thermo, Electron Corporation) working at 570 nm.
The MTT assay was performed, in total of ﬁve experiments
per extract.
The lactate dehydrogenase assay was also performed to
evaluate whether the tested extracts were cytotoxic to cells in the
experimented concentrations. LDH converts pyruvate to lactate
using NADH as a cofactor. The procedure was adapted from
[22], and is based on the determination of NADH disappearance.
This was monitored with a Multiskan Ascent plate reader
(Thermo, Electron Corporation), in kinetic function, at
340 nm. A decrease in the absorbance is linked directly to the
quantity of LDH released by the cells in the culture
environment. The supernatant of every single well of the 48-
well plates, in which the cells were treated with the extracts
and the LDH assay was performed, in total of ﬁve
experiments per extract.
2.10. Statistical analysis
All data were recorded as mean ± standard deviation of
triplicate determinations. Mean values were compared using two
way ANOVA and Bonferroni test, as post hoc test, were used to
determine differences with statistical signiﬁcance. Differences
were considered signiﬁcant for P < 0.05. Statistical analysis was
carried out using: Graphpad Prism 5 Software (San Diego, CA,
USA).
3. Results
3.1. Phenolic compounds
The HPLC analysis of E. uchi bark extracts allowed the
identiﬁcation of ﬁve phenolic compounds, which comprised the
bergenin (5) and four bergenin derivatives (1–4) (Figure 1 and
Table 1). Among the identiﬁed compounds, bergenin (5) was
previously reported by [9]. Both extracts showed a similarproﬁle, some differences in quantitative composition were
observed (Table 1).
The total amounts obtained for both extracts were 179289.0
and 225644.2 mg/kg of dried extract for hydroethanolic and
infusion, respectively. The most representative compound in
each extract was bergenin (5) with 87.6 and 88.7% for hydro-
ethanolic and infusion, respectively.
3.2. Antioxidant activity
The evaluation of hydroethanolic and infusion extracts of
E. uchi bark as scavenger was performed against DPPH, O2

−
and NO radicals (Figure 2 and Table 2). The antioxidant activity
of E. uchi infusion extract was previously reported against
DPPH, however the authors did not determine the IC50 [1],
being the scavenging activity of E. uchi against nitric oxide
and super-oxide radicals reported for the ﬁrst time in this work.
The both tested extracts exhibited a dose-dependent effect
against DPPH (Figure 2A), without signiﬁcant differences
among them, infusion being the most active (IC50 = 27 mg/mL),
followed by hydroethanolic extract (IC50 = 33 mg/mL) (Table 2).
The analysed extracts were particularly active against su-
peroxide radical, being hydroethanolic extract more active than
infusion (IC50 = 12 mg/mL and IC50 = 33 mg/mL, respectively)
(Figure 2B, Table 2). Infusion was slightly more active against
nitric oxide (IC50 = 24 mg/mL) comparatively hydroethanolic
extract (IC50 = 29 mg/mL) (Table 2).
Figure 2. Effect of E. uchi extracts against (A) DPPH, (B) superoxide
radical and (C) nitric oxide radical.
Figure 3. Inhibition of E. uchi extracts against (A) AChE and (B) BuChE.
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Under the assays conditions to ﬁnd inhibitors of ChE (acetyl
and butyryl) a concentration-dependent inhibitory effect on the
two enzymes were observed (Figure 3), being the AChE and
BuChE activities of E. uchi bark extract reported in this work for
the ﬁrst time. The hydroethanolic extract was the most active
against the both enzymes, with IC25 = 200 mg/mL and
IC25 = 309 mg/mL for AChE and BuChE, respectively (Figure 3
and Table 2).Table 2
IC25 and IC50 (mg/mL) values found in the antioxidant activity assays for
E. uchi extracts.
Assay IC Ethanol: water Infusion
DPPH IC50 33.0 ± 1.7 27.0 ± 1.5
a
Superoxide IC50 12.0 ± 0.9 33.0 ± 2.3
Nitric oxide IC50 29.0 ± 1.5 24.0 ± 3.1
a
AChE IC25 200.0 ± 115.6 454.0 ± 33.1
BuChE IC25 309.0 ± 4.0 500.0 ± 25.2
a-Glucosidase IC50 2.2 ± 0.1 2.4 ± 0.1
a
Values are expressed as mean ± standard deviation of three assays.
a Compared the samples there are not signiﬁcant differences (P > 0.05).3.4. a-Glucosidase inhibitory activity
In the present study, we tested for the ﬁrst time the a-
glucosidase inhibitory effect of the hydroethanolic and infusion
extracts of E. uchi bark, both were able to inhibit the a-gluco-
sidase in a dose-dependent manner, with an IC50 = 2.2 mg/mL
and IC50 = 2.4 mg/mL for hydroethanolic and infusion extracts,
respectively (Figure 4 and Table 2). On the other hand, these
results obtained for both extracts are much lower compared to
positive control acarbose (IC50 = 284 mg/mL), revealing a great
potential to inhibit this enzyme.
3.5. Antibacterial activity
The antibacterial activity of E. uchi extracts has been
investigated against several Gram-negative and Gram-positive
bacterial strains and MIC and MLC values were determined.
By the analysis of the obtained results, there was no considerable
variation between the MIC and MLC found among the different
studied bacteria and extracts (Table 3). The infusion showed
good bacteriostatic and bactericidal activity against Gram-Figure 4. Inhibition of E. uchi extracts against a-glucosidase.
Table 3
MIC and MLC of E. uchi extracts against selected bacteria.
Extracta Gram-positive Gram-negative
S. aureus Staphylococcus
epidermidis
M. luteus Enterococcus
faecalis
B. cereus Proteus
mirabilis
E. coli P. aeruginosa Salmonella
typhimurium
MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC MIC MLC
Infusion 6.6 6.6 >6.6 >6.6 6.6 >6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6 3.3 3.3 6.6 6.6
Ethanol:
water
6.6 6.6 6.6 6.6 1.7 1.7 6.6 6.6 0.8 6.6 >6.6 >6.6 >6.6 >6.6 6.6 6.6 >6.6 >6.6
Figure 5. Effect of E. uchi infusion extract in cell viability.
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sensitive to hydroethanolic extract (Table 3).
3.6. Effect of E. uchi extracts in Caco-2 cell viability
As referred above, E. uchi bark infusions are commonly used
in traditional medicine to treatment the diabetes [1]. Although the
use is spread throughout the world, as far as we know there
effect on human intestinal cells has not been scientiﬁcally
evaluated before. Therefore, we have used a human colorectal
adenocarcinoma cell line (Caco-2), in which cells were
exposed to E. uchi bark infusion extract (0.016–1.000 mg/mL)
for 24 h. Cell viability was evaluated by the MTT reduction
and LDH release assays (Figure 5).
4. Discussion
The results obtained for phenolic compounds conﬁrm that
bergenin is the main one in E. uchi tea bark [9], this compound
have been reported to exhibit various biological activities such
as antiulcer, antihepatotoxic, anti-HIV, antiarrhythmic, neuro-
protective, antifungal, anti-inﬂammatory, immunomodulatory
and burn wound healing effects [23].
An antioxidant may be deﬁned as ‘any substance that when
present at relatively low concentrations, compared with those of
the oxidisable substrate, signiﬁcantly delays or inhibits oxidation
of that substrate’ [24]. Reactive oxygen species (ROS) such as
superoxide anion (O2
–), hydroxyl (OH), peroxyl (ROO), and
alkoxyl radicals (RO), hydrogen peroxide (H2O2), and singlet
oxygen (O2
1Dg) may attack biological macromolecules, giving
rise to protein, lipid, and DNA damage, cell aging, oxidative
stress-originated diseases (e.g., cardiovascular and neurodegen-
erative diseases), and cancer. Antioxidants scavenge or quench
ROS and reactive nitrogen species (RNS) products of respira-
tion, including free radicals [24].DPPH is a stable free radical, which provides a good indi-
cation of a sample's anti-radical potential. The activity observed
against this radical may be due in large part to phenolic com-
pounds, namely bergenin and bergenin derivatives, whose anti-
radical proprieties are known [25,26]. Additive or synergistic
interactions might occur between phenolic compounds and
other non-determined active compounds. These results are
similar to those obtained by our research group with Satureja
parvifolia decoction extract harvested in the same region and
tested under the same conditions, with IC50 around 30 mg/mL [2].
Subsequently, the extracts were also tested against other free
radicals present in the human body, namely superoxide (O2
C-)
and nitric oxide (CNO) radicals. Superoxide radical is one of the
most effective free radicals, being implicated in cell damage as
precursor of other important reactive oxygen species (ROS),
such as hydroxyl radical and peroxy-nitrite, contributing to the
pathological process of many diseases [27]. Hydroethanolic
extract was more active than infusion (IC50 = 12 mg/mL and
IC50 = 33 mg/mL, respectively). This activity may be
associated with the presence of high level of phenolic
compounds in both extracts, more speciﬁcally with the
presence of bergenin and bergenin derivatives [25,26,28].
However the presence of other non-determined bioactive
compounds cannot be ignored, since the infusion showed the
higher amounts in phenolic compounds and was less active.
Nitric oxide is a molecule with important biological func-
tions, including blood pressure control, neural signal trans-
duction and antimicrobial protection, which have an important
role in the inﬂammation process [27]. Nevertheless, nitric oxide
can be responsible for oxidative damage. Besides its own
toxicity, this radical can further react with other species,
instigating even more toxic radicals, such as peroxynitrite that
results from its reaction with superoxide.
Concerning nitric oxide scavenging, infusion was slightly
more active (IC50 = 24 mg/mL) comparatively hydroethanolic
extract (IC50 = 29 mg/mL). The results obtained for all assays
revealed that E. uchi extracts possess a strong antioxidant ac-
tivity without great differences between the both analyzed
extracts.
Alzheimer's disease (AD) is the most prevalent neurode-
generative disease without known cure, affects approximately
10% of the population older than 65 years of age. Clinical
manifestations of AD are severe impairments in thought,
learning, memory and language abilities [29].
Cholinesterases (ChE) are ubiquitous constituents of cholin-
ergic pathways, they are responsible for the termination of the
nerve impulse transmission at the cholinergic synapses by fast
hydrolysis of acetylcholine (ACh) [30]. The inhibition of ChE is
the major goal of cholinoactive drugs prescribed for AD,
neurotoxins used as insecticides and nerve gases intended for
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the cortex, modulating cortical processing and responses to new
and relevant stimuli. BuChE-positive neurons project specif-
ically to the frontal cortex, and may have roles in attention,
executive function, emotional memory and behavior [31].
Furthermore, BuChE activity progressively increases as the
severity of dementia advances, while AChE declines, their
inhibition may provide additional beneﬁts [31].
The hydroethanolic extract was the most active against the
both enzymes, with IC25 = 200 mg/mL and IC25 = 309 mg/mL for
AChE and BuChE, respectively. Comparing the results obtained
with literature data, the effect observed herein on both enzymes
were interesting than that found with hydromethanolic extract of
Spergularia rubra and Satureja parvifolia tested in the same
concentrations with IC25 = 3680 mg/mL and 1360 mg/mL for
AChE and IC25 = 4290 mg/mL and 1646 mg/mL for BuChE,
respectively [2,32]. On the other hand, concerning AChE
inhibition the extract revealed apparently to be more active
than the positive control phytostigmine (IC50 = 1770 mg/mL)
tested before under the same conditions [33].
Additionally, in a previous work, Takahashi and co-authors
[34] synthesized a series of bergenin derivatives and tested
their effect on the viability in rat cortical neurons, some of
them showed protection of neuronal death on the primary
culture of rat cortical neurons, providing their neuroprotective
effect.
The term diabetes mellitus describes a metabolic disorder of
multiple etiologies characterized by chronic hyperglycaemia
with disturbances of carbohydrate, fat and protein metabolism
resulting from defects in insulin secretion, insulin action or both.
The causes of type 2 diabetes are either a predominant insulin
resistance with a relative insulin deﬁciency or a predominant
insulin secretory defect with or without insulin resistance [35]. a-
Glucosidase inhibitors (AGIs) are among the available glucose-
lowering medications. The a-glucosidase enzyme is located in
the brush border of the small intestine and is required for the
breakdown of carbohydrates to absorbable monosaccharides.
The AGI delay, but not prevent, the absorption of ingested
carbohydrates, reducing the postprandial glucose and insulin
peaks [36]. In recent years, several researchers have focused on
the AGIs of medicinal plants [37].
The E. uchi bark extracts showed a considerable better in-
hibition than those obtained previously with other plants used in
the treatment of the diabetes, namely Cecropia otusifolia
(IC50 = 14 mg/mL), Malmea depresa (IC50 = 21 mg/mL),
Acosmium panamense (IC50 = 109 mg/mL) [37] and Spergularia
rubra (IC50 = 2550 mg/mL) [32]. According to the results
obtained herein, the inhibition of a-glucosidase may be one of
the mechanisms associated with the use of this plant in the
treatments of diabetes.
The results obtained may be attributed, at least partially, to
the composition of the extracts concerning bergenin and ber-
genin derivatives. Kumar and co-authors [13] tested the type 2
antidiabetic activity of bergenin in diabetic rats, the results
obtained allowed the authors to conclude that bergenin
possesses signiﬁcant antidiabetic, hypolipidemic and
antioxidant activity in type 2 diabetic rats.
Concerning antibacterial activity, P. aeruginosa was the most
sensitive species for infusion (MIC and MLC = 3.3 mg/mL for
both), this bacteria has been recognized as a frequent inhabitant
of chronic non-healing wounds and is one of the mostopportunistic bacteria isolated from wounds which cause high
morbidity and mortality despite antimicrobial therapy [38].
Additionally, the hydroethanolic extract was more active
against B. cereus (MIC = 0.8 mg/mL and MLC = 6.6 mg/mL)
and M. luteus (MIC = 1.7 mg/mL and MLC = 1.7 mg/mL).
B. cereus is ubiquitous organisms, present in virtually all envi-
ronments, their spores and cells are common in soil and dust and
can be readily isolated in soil and dust and can be readily iso-
lated in small numbers from many foods, which include both
raw and ﬁnished products such as milk and milk product.
B. cereus may produce emetic toxin and diarrheal enterotoxins
which cause two types of gastrointestinal diseases – emesis and
diarrhea [39]. M. luteus has been implicated in a variety of
infections, including meningitis, endocarditis, septic arthritis
and central nervous system infections in immunocompromised
hosts [40].
Silva and co-authors [6] evaluated the antibacterial activity of
E. uchi aqueous extracts against several microorganisms,
including E. coli, P. aeruginosa, E. faecallis and S. aureus,
the authors reported that the extract had no effect; however the
concentrations tested were much lower than in our study those
reported. In another study, Politi and co-authors [1] reported a
little inhibition haloes against ﬁve bacteria, being observed a
little effect against S. aureus with 10% infusion extracts of
E. uchi.
To check whether the observed antibacterial activity could be
due to the presence of identiﬁed phenolic compounds, it is also
possible that other bioactive compounds exists in the extracts,
that interfere with the real antimicrobial potential, like tannins
and organic acids [6,10,19].
The MTT assay evaluated the mitochondrial function, the
mitochondrial dehydrogenase of viable cells reduce the yellow
tetrazolium salt forms purple formazan crystals. Infusion extract
was not shown to be toxic to Caco-2 cells accordingly to the
MTT assay, revealing a signiﬁcant increase in MTT reduction of
cells treated with infusion in a dose-dependent manner, being
obtained a MTT reduction higher than 118% at concentration of
1 mg/mL. As the experiments were carried out after cellular
conﬂuence, these results are hardly explained by an increase in
cellular proliferation. It is possible that the cell stress caused by
extract increased mitochondrial activity, and consequently MTT
reduction [41].
LDH leakage is well known as a useful index for cell via-
bilities on the basis of loss of membrane integrity. Infusion
extract has no effect on LDH leakage from Caco-2 cells.
Taking into account that the infusion of E. uchi extract
showed no effect on human colorectal Caco-2 cell viability, and
as described before also possess a great inhibitory effect against
a-glucosidase enzyme in lower concentrations for the tested on
cell viability, the results obtained herein proved that the E. uchi
infusion may be used safely as antidiabetic.
The study reported herein describes, for the ﬁrst time, some
biological properties of E. uchi bark, as well as phenolics
quantiﬁcation. The results indicate that E. uchi bark extracts are
a rich source of bergenin and bergenin derivatives showing a-
glucosidase, antibacterial and cholinesterases (AChE and
BuChE) inhibitory properties and radical scavenging capacity.
This study adds value knowledge to the species and represents a
basis for the quality control of this plant drug. Therefore, E. uchi
bark may be considered as one plant part with great antidiabetic
potential. However, further investigations are required to incite
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pharmaceutical industries.
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